Literature DB >> 25556372

MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.

Zhen Liang1, Shiqi Li1, Xin Xu1, Xianglai Xu1, Xiao Wang1, Jian Wu1, Yi Zhu1, Zhenghui Hu1, Yiwei Lin1, Yeqing Mao1, Hong Chen1, Jindan Luo1, Ben Liu1, Xiangyi Zheng1, Liping Xie1.   

Abstract

MicroRNAs (miRNAs) are small, endogenous RNAs that play important gene-regulatory roles by binding to the imperfectly complementary sequences at the 3'-UTR of mRNAs and directing their gene expression. Here, we first discovered that miR-576-3p was down-regulated in human bladder cancer cell lines compared with the non-malignant cell line. To better characterize the role of miR-576-3p in bladder cancer cells, we over-expressed or down-regulated miR-576-3p in bladder cancer cells by transfecting with chemically synthesized mimic or inhibitor. The overexpression of miR-576-3p remarkably inhibited cell proliferation via G1-phase arrest, and decreased both mRNA and protein levels of cyclin D1 which played a key role in G1/S phase transition. The knock-down of miR-576-3p significantly promoted the proliferation of bladder cancer cells by accelerating the progression of cell cycle and increased the expression of cyclin D1. Moreover, the dual-luciferase reporter assays indicated that miR-576-3p could directly target cyclin D1 through binding its 3'-UTR. All the results demonstrated that miR-576-3p might be a novel suppressor of bladder cancer cell proliferation through targeting cyclin D1.

Entities:  

Keywords:  bladder cancer; cyclin D1; microRNA-576-3p; proliferation

Mesh:

Substances:

Year:  2014        PMID: 25556372      PMCID: PMC4332027          DOI: 10.14348/molcells.2015.2146

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  34 in total

Review 1.  MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.

Authors:  S Patrick Nana-Sinkam; Carlo M Croce
Journal:  IDrugs       Date:  2010-12

Review 2.  Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.

Authors:  A Satyanarayana; P Kaldis
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

Review 3.  MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.

Authors:  William C S Cho
Journal:  Int J Biochem Cell Biol       Date:  2009-12-22       Impact factor: 5.085

4.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

5.  MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma.

Authors:  Jiamin Chen; Harriet E Feilotter; Geneviève C Paré; Xiao Zhang; Joshua G W Pemberton; Cherif Garady; Dulcie Lai; Xiaolong Yang; Victor A Tron
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

Review 6.  Regulation of cyclin D1 gene expression.

Authors:  Ini-Isabée Witzel; Li Fang Koh; Neil D Perkins
Journal:  Biochem Soc Trans       Date:  2010-02       Impact factor: 5.407

7.  MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells.

Authors:  Hongping Xia; Yanting Qi; Samuel S Ng; Xiaona Chen; Shen Chen; Marong Fang; Dan Li; Yu Zhao; Ruiguang Ge; Guo Li; Yangchao Chen; Ming-Liang He; Hsiang-fu Kung; Lihui Lai; Marie C Lin
Journal:  Biochem Biophys Res Commun       Date:  2009-01-09       Impact factor: 3.575

Review 8.  MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

Authors:  James W F Catto; Antonio Alcaraz; Anders S Bjartell; Ralph De Vere White; Christopher P Evans; Susanne Fussel; Freddie C Hamdy; Olli Kallioniemi; Lourdes Mengual; Thorsten Schlomm; Tapio Visakorpi
Journal:  Eur Urol       Date:  2011-02-01       Impact factor: 20.096

9.  The present and future burden of urinary bladder cancer in the world.

Authors:  Martine Ploeg; Katja K H Aben; Lambertus A Kiemeney
Journal:  World J Urol       Date:  2009-02-15       Impact factor: 4.226

10.  PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.

Authors:  Jian-Ye Liu; Dong Qian; Li-Ru He; Yong-Hong Li; Yi-Ji Liao; Shi-Juan Mai; Xiao-Peng Tian; Yan-Hui Liu; Jia-Xing Zhang; Hsiang-Fu Kung; Yi-Xin Zeng; Fang-Jian Zhou; Dan Xie
Journal:  Mol Cancer       Date:  2013-11-23       Impact factor: 27.401

View more
  17 in total

1.  MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway.

Authors:  Huaqing Yan; Jiangfeng Li; Yufan Ying; Haiyun Xie; Hong Chen; Xin Xu; Xiangyi Zheng
Journal:  Cell Cycle       Date:  2018-12-18       Impact factor: 4.534

2.  Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion.

Authors:  Evan J Greenawalt; Mick D Edmonds; Neha Jain; Clare M Adams; Ramkrishna Mitra; Christine M Eischen
Journal:  Mol Cancer Res       Date:  2018-09-26       Impact factor: 5.852

3.  Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.

Authors:  Jie Ma; Yanli Lin; Min Zhan; Dean L Mann; Sanford A Stass; Feng Jiang
Journal:  Lab Invest       Date:  2015-07-06       Impact factor: 5.662

Review 4.  Novel non invasive diagnostic strategies in bladder cancer.

Authors:  Anamaria Truta; Tudor Adrian Hodor Popon; George Saraci; Liviu Ghervan; Ioan Victor Pop
Journal:  Clujul Med       Date:  2016-04-15

Review 5.  The role of microRNAs in bladder cancer.

Authors:  Hideki Enokida; Hirofumi Yoshino; Ryosuke Matsushita; Masayuki Nakagawa
Journal:  Investig Clin Urol       Date:  2016-06-07

6.  miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.

Authors:  Xiao Wang; Zhen Liang; Xin Xu; Jiangfeng Li; Yi Zhu; Shuai Meng; Shiqi Li; Song Wang; Bo Xie; Alin Ji; Ben Liu; Xiangyi Zheng; Liping Xie
Journal:  Cell Death Dis       Date:  2016-12-01       Impact factor: 8.469

7.  MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.

Authors:  Zhen Liang; Xiao Wang; Xin Xu; Bo Xie; Alin Ji; Shuai Meng; Shiqi Li; Yi Zhu; Jian Wu; Zhenghui Hu; Yiwei Lin; Xiangyi Zheng; Liping Xie; Ben Liu
Journal:  Mol Cancer       Date:  2017-05-26       Impact factor: 27.401

8.  Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1'S-1'-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4.

Authors:  Neoh Hun Phuah; Mohamad Nurul Azmi; Khalijah Awang; Noor Hasima Nagoor
Journal:  Mol Cells       Date:  2017-04-12       Impact factor: 5.034

9.  MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.

Authors:  Jiangfeng Li; Xin Xu; Shuai Meng; Zhen Liang; Xiao Wang; Mingjie Xu; Song Wang; Shiqi Li; Yi Zhu; Bo Xie; Yiwei Lin; Xiangyi Zheng; Ben Liu; Liping Xie
Journal:  Cell Death Dis       Date:  2017-08-24       Impact factor: 8.469

10.  c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling.

Authors:  X Xu; Y Zhu; Z Liang; S Li; X Xu; X Wang; J Wu; Z Hu; S Meng; B Liu; J Qin; L Xie; X Zheng
Journal:  Cell Death Dis       Date:  2016-02-04       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.